Experiencing uncertain HIV treatment delivery in a transitional setting: Qualitative study

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 21, Issue 3, 2009, Pages 315-321

  Bernays, Sarah ^a   Rhodes, Tim ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Adherence; HIV treatment; Montenegro; Qualitative; Rationing; Serbia; Uncertainty

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGED; ANXIETY; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; ENERGY; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH SERVICE; HOPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MONTENEGRO (REPUBLIC); PRIORITY JOURNAL; QUALITATIVE RESEARCH; SERBIA; SOCIAL CHANGE; STIGMA; VIRUS MUTATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; ANTI-HIV AGENTS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MIDDLE AGED; MONTENEGRO; QUALITATIVE RESEARCH; SERBIA; UNCERTAINTY; YOUNG ADULT;

EID: 70449640304     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120802183495     Document Type: Article

References (39)

1. Bayer, R., & Oppenheimer, G. (2007). Scale ups, scaracity and selections: The experience of doctors in South Africa. AIDS, 21(Suppl. 5), S43-S47.
2. Bernays, S., Rhodes, T., & Prodanovic, A. (2007). HIV treatment access, delivery and uncertainty: A qualitative study in Serbia and in Montenegro. Belgrade: United Nations Development Program.
3. Brashers, D.E., Neidig, J.L., Cardillo, L.W., Dobbs, K.W., Russell, J.A., & Haas, S.M. (1999). 'In an important way, I did die': Uncertainty and revival in persons living with HIV and AIDS. AIDS Care, 11, 201-219.
4. Brashers, D.E., Neidig, J.L., Russell, J.A., Cardillo, L.W., Haas, S.M., Dobbs, L.K., et al. (2003). The medical, personal and social causes of uncertainty in HIV illness. Issues in Mental Health Nursing, 24, 497-522.
5. Carricaburu, D., & Pierret, J. (1995). From biographical disruption to biographical reinforcement: The case of HIV positive men. Sociology of Health and Illness, 17, 65-88.
6. Chesney, M. (2003). Adherence to HAART regimens. AIDS Patient Care STDS, 17, 160-177.
7. Chidwick, A., & Borrill, J. (1996). Dealing with a lifethreatening diagnosis: The experience of people with the human immunodeficiency virus. AIDS, 8, 271-284.
8. Crabb, C. (2006). SMART researchers plan followthrough. AIDS, 20, N5-N6.
9. Crossley, M.L. (1998). 'Sick role' or 'Empowerment'? The ambiguities of life with a HIV positive diagnosis. Social Science and Medicine, 20, 507-531.
10. Curran, J., Debas, H., Arya, M., Kelley, P., Knobler, S., & Pray, L. (2005). Scaling up treatment for the Global AIDS pandemic: Challenges and opportunities. Committee on examining the probable consequences of alternative patterns of widespread antiretroviral drug use in resource constrained settings. Washington, DC: National Academic Press.
11. Davies, M. (1997). Shattered assumptions: Time and the experience of long-term HIV positivity. Social Science and Medicine, 44, 561-571.
12. Davis, M. (2007). Identity, expertise and HIV risk in a case study of reflexivity and medical technologies. Sociology, 41(6), 1003-1019.
13. Davis, M., Frankis, J., & Flowers, P. (2006). Uncertainty and 'technological horizon' in qualitative interviews about HIV treatment. Health, 10, 323-344.
14. Elford, J., Bolding, G., & Sherr, L. (2002). High-risk sexual behaviour increases among London gay men between 1998 and 2001: What is the role of HIV optimism? AIDS, 16, 1537-1544.
15. Ezzy, D. (2000). Illness narratives: Time, hope and HIV. Social Science and Medicine, 50, 605-617.
16. Farmer, P., Leandre, F., Mukherjee, J., Gupta, R., Tarter, L., & Yong Kim, J. (2001). Community-based treatment of advanced HIV disease: Introducing DOTHAART (directly observed therapy with highly active antiretroviral therapy). Bulletin of WHO, 79, 1145- 1151.
17. Farmer, P., Léandre, F., Mukherjee, J., Sidonise, C.M., Nevil, P., Smith-Fawzi, M., et al. (2001). Communitybased approaches to HIV treatment in resource-poor settings. Lancet, 358(9279), 404-409.
18. IRIN. (2006a). Togo: End of grant causes concern. Nairobi: Author.
19. IRIN. (2006b). Zambia: ARV Rollout-quality Not Quantity? Nairobi: Author.
20. IRIN. (2007). Burundi: Outrage and concern over national ARV strategies. Nairobi: Author.
21. Kasanga, K., & Bainemigisha, H. (2006, September 19). Doctor urges on ARV scarcity. New Vision. Accessed from www.newvision.co.ug on 20th September 2006.
22. Kielmann, K., Deshmukh, D., Deshpande, S., Datye, V., Porter, J., & Rangan, S. (2005). Managing uncertainty around HIV/AIDS in an urban setting: Private medical providers and their patients in Pune, India. Social Science and Medicine, 61, 1540-1550.
23. Kim, J.Y., & Farmer, P. (2006). AIDS in 2006- Moving toward one world, one hope? New England Journal of Medicine, 355(7), 645-647.
24. Knapp, C. (2004). Antiretrovirals give newhope and new life to South Africans. Lancet, 363, 1710.
25. Kyokuhaire, G. (2006, July 25). ARVs will kill more Ugandans. New Vision. Accessed from www.newvision. co.ug on 26th July 2006.
26. Lange, J., Perriens, J., Kuritzkes, D., & Zewdie, D. (2004). What policymakers should knowabout drug resistance and adherence in the context of scaling-up treatment of HIV infection. AIDS, 18(Suppl. 3), S69-S74.
27. Leclerc-Madlala, S. (2006). We will eat when I get the grant': Negotiating AIDS, poverty and antiretroviral treatment in South Africa. African Journal of AIDS Research, 5(3), 249-256.
28. Martin, D.J., & Sim, J. (2005). Laboratory requirements for scaling up HIV treatment. Paper presented at the 12th conference on retroviruses and opportunistic infections, Boston.
29. Pai, N.P., Lawrence, J., Reingold, A.L., & Tulsky, J.P. (2006). Structured treatment interruption (STI) in chronic unsuppressed HIV infection in adults. Cochrane Database Systematic Review 3, CD006148.
30. Rhodes, T., & Simic, M. (2005). Transition and the HIV risk environment. British Medical Journal, 331, 220- 223.
31. Rosengarten, M., Miris, J., Flowers, P., Davis, M., & Hart, G. (2004). After the euphoria: HIV medical technologies from the perspective of their prescribers. Sociology of Health and Illness, 26, 575-596.
32. Selwyn, P., & Arnold, R. (1998). From fate to tragedy: The changing meaning of life, death and AIDS. Annals of Internal Medicine, 129, 899-902.
33. Siegal, K., & Lekas, H. (2002). AIDS as a chronic illness: Psychosocial implications. AIDS, 16, S69-S76.
34. Silverman, D. (2000). Doing qualitative research: A practical handbook. London: Sage.
35. Simic, D. (2006). The epidemiological situation of HIV/ AIDS in Serbia in the period 1984-30th June 2006. Belgrade: Centre for Prevention and Control of Infectious Diseases, Institute of Public Health of Serbia.
36. Thimothy, R., Kumar, A., & Irudaya Rajan, S. (2006). Viability of providing HIV/AIDS care in public sector: A case study. Journal of Health Management, 8(1), 65-78.
37. Tiamson, M. (2002). Challenges in the management of the HIV patient in the third decade of AIDS. Psychiatric Quarterly, 73, 51-58.
38. Weitz, R. (1989). Uncertainty and the lives of persons with AIDS. Journal of Social Health and Behaviour, 30, 270-281.
39. WHO. (2003). Médicins sans Frontières South Africa, Department of Public Health at University of Cape Town, Provincial Administration of Western Cape, South Africa. Antiretroviral therapy in primary health care: Experience of the Khayelitsha Programme in South Africa. Geneva: Author.